Celgene

Global integrated biopharmaceutical company Celgene is certainly not afraid to challenge itself, and remains dedicated to treating some of the most complicated and serious conditions. Specifically, the industry leader creates life-changing drugs for cancer and severe, immune inflammatory conditions – where patients tend to have limited medicinal options. Celgene, which began in 1986, is committed to honest and transparent communication, as well as a diverse workplace. It prides itself on its passion and courage, and also believes in an “ecosystem of innovation” – whereby it collaborates with other businesses and academics across the world to enhance the lives of all its patients.